PIM2 and breast cancer: PIM2 can directly bind and change the phosphorylation status of PFKFB3 at Ser478 to enhance stability through the ubiquitin−proteasome pathway and to promote glycolysis, BC cell growth, and paclitaxel resistance together with PIM2 in vitro and in vivo (47).